One shot could ease knee pain for a year: new hydrogel tested

NCT ID NCT07465601

Ongoing Symptom relief Sponsor: Medisch Centrum Latem Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests a single injection of Arthrosamid, a hydrogel made mostly of water, in 29 people with painful knee osteoarthritis. The goal is to see if it improves daily activity and reduces symptoms over 12 months. Participants wear an activity tracker to measure changes, and the results could lead to a simple, non-surgical option for knee pain.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Arthrosamid (a hydrogel made mostly of water and a small amount of polyacrylamide)
What this could lead to: If it works, this could offer a simple, one-time injection to help people with knee osteoarthritis move better and feel less pain for up to a year.
What could go wrong: This is a small, early study with only 29 people, so results may not apply to everyone. It is also a device, not a drug, so it may not work for all types of knee arthritis.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for KNEE OSTEOARTHRISTIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

osteoarthritis, knee

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

KNEE OSTEOARTHRISTIS

Contacts and locations

Locations

Medisch Centrum Latem

Sint-Martens-Latem, Oost-Vlaanderen, 9830, Belgium

More trials for these conditions

Other studies related to the condition(s) this trial covers.